Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Return on Equity (2024 - 2026)

Kura Oncology has reported Return on Equity over the past 3 years, most recently at 0.0% for Q1 2026.

  • Quarterly Return on Equity changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Equity was 0.0% for Q1 2026 at Kura Oncology, down from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q4 2025 and troughed at 0.01% in Q3 2025.
  • The 3-year median for Return on Equity is 0.0% (2024), against an average of 0.0%.
  • The largest YoY upside for Return on Equity was 0bps in 2025 against a maximum downside of 0bps in 2025.
  • A 3-year view of Return on Equity shows it stood at 0.0% in 2024, then surged by 100bps to 0.0% in 2025, then crashed by -7959bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for KURA's Return on Equity are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025).